This site complies with the HONcode standard for trustworthy health information:
verify here.

Rewarding for
you and us
Defeat Diabetes Foundation

Defeat Diabetes
Foundation
150 153rd Ave,
Suite 300
Madeira Beach, FL 33708

Drugs

Search our News Articles Archives for diabetes and health news. Search by word or phrase. The latest article will appear first.

ROADMAP Study Demonstrates Significant Reduction of Early Kidney Disease in Type 2s

Posted: Wednesday, May 20, 2009

ROADMAP is the first-ever, large-scale clinical trial, being conducted in 19 European countries to evaluate whether the angiotensin II receptor blocker (ARB) olmesartan medoxomil can prevent the onset of microalbuminuria in patients with Type 2 diabetes (T2DM).

Pharmacists Prove their Worth in Diabetes Management

Posted: Wednesday, May 20, 2009

Pharmacists show why they need to be part of the “Diabetes Team” and the Ten City Challenge diabetes education program shows that they can also reduce costs ($1,079/patient) as well as reducing A1c levels along with cholesterol and blood pressure.

New Guidelines Address Treatment of Hospitalized Patients with High Blood Sugars

Posted: Wednesday, May 20, 2009

A consensus statement of the American Association of Clinical Endocrinologists (AACE) and the American Diabetes Association (ADA) issues clinical recommendations on the proper treatment of hospitalized patients with high blood glucose levels.

Lyrica Significantly Reduced Peripheral Nerve Pain

Posted: Wednesday, May 20, 2009

Patients suffering from post-traumatic peripheral nerve pain treated with Lyrica® (pregabalin) capsules CV experienced significantly reduced pain compared to those taking placebo, according to new data.

CHMP Recommends Approval of Novo Nordisk's Victoza(R) (Liraglutide) for Type 2 Diabetes

Posted: Wednesday, May 20, 2009

Novo Nordisk announces that the Committee for Medicinal Products for Human Use (CHMP), under the European Medicines Agency (EMEA) adopted a positive opinion, recommending marketing authorization, for Victoza® for the treatment of Type 2 diabetes.

Basal-Bolus Injection vs. Basal-Bolus Insulin Pump in Type 1s

Posted: Wednesday, May 20, 2009

To compare injects by syringe and using an insulin pump a randomized open parallel multicenter study was done.

GlucoStories - Join the Race With American Diabetes Wholesale & Charlie Kimball

Posted: Monday, May 18, 2009

Diabetes company and race car driving star join forces to launch new diabetes support site and contest.

Golden Rice Potential

Posted: Saturday, May 16, 2009

"Golden rice," a genetically modified grain that incorporates beta-carotene, has recently shown to help "convert vitamin A" in humans. This finding suggests that golden rice could help prevent vision loss and blindness in people suffering from vitamin A deficiency, especially those in poor, heavily rice-consuming countries. Many poor countries also suffer from high cases of diabetes, which can result in vision loss due to retinopathy.

Calls For More International Diabetes Funding

Posted: Friday, May 15, 2009

At a recent international meeting concerning non-communicable diseases, held in Doha, Qatar, professor Martin Slink, the president of the International Diabetes Federation (IDF), stressed the importance of more funding for diabetes, as well as other non-communicable diseases. Professor Slink specifically urged that an international effort to fight these diseases be added to the United Nations millennium development goals (MDGs).

Cost Of Diabetes Non-Adherence $11,000 Yearly Per Patient

Posted: Tuesday, May 12, 2009

Costs of not taking medications as prescribed have an impact on the US economy increasing the costs up to $100 billion per year. In addition, poor adherence to antidiabetic medications might explain why 43% of patients with diabetes mellitus do not reach adequate glycemic control.